Die Pharmakotherapie neuropathischer Schmerzen Individuell ausgerichtet, aber eingebettet in ein interdisziplin?res und multimodales Konzept

Diabetes Aktuell

Volumn 5, Issue 4, 2007, Pages 167-174

  Freynhagen, Rainer ^a   Baron, Ralf ^b   Koroschetz, Jana ^b   Rehm, Stefanie ^b   Ziegler, Dan ^c  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84898048089     PISSN: 18616089     EISSN: 18641733     Source Type: Journal    
DOI: 10.1055/s-2007-986537     Document Type: Article

References (33)

1. Attal N, Cruccu G, Haanpaa M et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006; 13(11): 1153–1169
2. Baron R, Maier C. Opioids in neuropathic pain. Akt Neurologie 2000; 27: 332–339
3. Berman JS, Symonds C, Birch R. Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial. Pain 2004; 112(3): 299–306
4. Bernstein JE, Korman NJ, Bickers DR et al. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol 1989; 21 (2 Pt 1): 265–270
5. Bruehl S, Harden RN, Galer BS et al. External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. International Association for the Study of Pain. Pain 1999; 81 (1–2): 147–154
6. Collins SL, Moore RA, McQuay HJ, Wiffen P. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. J Pain Symptom Manage 2000; 20(6): 449–458
7. Eisenberg E, McNicol E, Carr DB. Opioids for neuropathic pain. Cochrane Database Syst Rev 2006; 3:CD006146
8. Eisenberg E, McNicol ED, Carr DB. Efficacy of muopioid agonists in the treatment of evoked neuropathic pain: systematic review of randomized controlled trials. Eur J Pain 2006; 10(8): 667–676
9. Finnerup NB, Otto M, McQuay HJ et al. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain 2005; 118 (3): 289–305
10. Finnerup NB, Sindrup SH, Bach FW et al. Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain 2002; 96 (3): 375–383
11. Freynhagen R, Baron R, Gockel U, Tolle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006; 22 (10): 1911–1920
12. Freynhagen R, Busche P, Konrad C, Balkenohl M. Wirksamkeit und Wirkungsbeginn von Pregabalin bei Patienten mit neuropathischen Schmerzen. Schmerz 2006; 20 (4): 285–288, 90–92
13. Freynhagen R, Muth-Selbach U, Lipfert P et al. The effect of mirtazapine in patients with chronic pain and concomitant depression. Curr Med Res Opin 2006; 22 (2): 2257–2264
14. Freynhagen R, Vogt J, Lipfert P, Muth-Selbach U. Mirtazapine and its enantiomers differentially modulate acute thermal nociception in rats. Brain Research Bulletin 2006; 69 (2): 168–173
15. Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol 1984; 15(3): 240–244
16. Gilron I, Bailey JM, Tu D et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 352 (13): 1324–1334
17. Goldstein DJ, Lu Y, Detke MJ et al. Duloxetine vs placebo in patients with painful diabetic neuropathy. Pain 2005; 116 (1–2): 109–118
18. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004; 112 (3): 372–380
19. Karst M, Salim K, Burstein S et al. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. JAMA 2003; 290 (13): 1757–1762
20. Morrison RS, Meier DE. Clinical practice. Palliative care. N Engl J Med 2004; 350 (25): 2582–2590
21. Moulin DE, Clark AJ, Gilron I et al. Pharmacological management of chronic neuropathic pain - Consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 2007; 12 (1): 13–21
22. No authors listed. Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Capsaicin Study Group. Diabetes Care 1992; 15 (2): 159–165
23. Otto M, Bak S, Bach FW et al. Pain phenomena and possible mechanisms in patients with painful polyneuropathy. Pain 2003; 101 (1–2): 187–192
24. Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996; 65 (1): 39–44
25. Rowbotham MC, Goli V, Kunz NR, Lei D. Venlafaxine extende release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 2004; 110 (3): 697–706
26. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2005 (3): CD005454
27. Sandkuhler J, Kress HG. Opioids for chronic nonmalignant and neuropathic pain. Eur J Pain 2005; 9 (2): 99–100
28. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999; 83 (3): 389–400
29. Svendsen KB, Jensen TS, Bach FW. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial. BMJ 2004; 329 (7460): 253
30. Vestergaard K, Andersen G, Gottrup H et al. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology 2001; 56 (2): 184–190
31. Wernicke JF, Pritchett YL, D'Souza DN et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006; 67 (8): 1411–1420
32. Ziegler D. Treatment of diabetic polyneuropathy: Update 2006. Ann N Y Acad Sci 2006; 1084: 250–266
33. Ziegler D, Nowak H, Kempler P et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 2004; 21 (2): 114–121